Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for LEVETIRACETAM

Ingredient

LEVETIRACETAM

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-LEVETIRACETAM	500MG	TABLET	Resolved	2024-07-04	2024-09-19	232217
TEVA-LEVETIRACETAM	500MG	TABLET	Resolved	2025-07-03	2025-12-18	261791
TEVA-LEVETIRACETAM	750MG	TABLET	Resolved	2023-06-08	2023-10-04	194106
TEVA-LEVETIRACETAM	750MG	TABLET	Resolved	2023-06-19	2023-10-04	195484
TEVA-LEVETIRACETAM	750MG	TABLET	Resolved	2025-04-04	2025-06-19	254124
TEVA-LEVETIRACETAM	750MG	TABLET	Resolved	2025-08-08	2026-01-08	264795

Previous
1
…
11
12
13

Showing 121 to 126 of 126

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-LEVETIRACETAM	500MG	TABLET	Discontinued	2020-01-24	2020-01-24	104304
LEVETIRACETAM	250MG	TABLET	Discontinued	2020-05-29	2021-10-27	116076
LEVETIRACETAM	500MG	TABLET	Discontinued	2020-06-15	2021-10-27	117912
LEVETIRACETAM	750MG	TABLET	Discontinued	2021-11-15	2021-11-15	149323
NAT-LEVETIRACETAM	250MG	TABLET	Discontinued	2025-12-05	2025-12-06	273390
NAT-LEVETIRACETAM	500MG	TABLET	Discontinued	2025-12-05	2025-12-06	273434
NAT-LEVETIRACETAM	750MG	TABLET	Discontinued	2025-12-05	2025-12-06	273437

1

Showing 1 to 7 of 7